| Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
|---|
| 05/30/2013 | WO2013075199A1 Acyl-hydrazone and oxadiazole compounds, pharmaceutical compositions containing the same and uses thereof |
| 05/30/2013 | US20130137740 Combretastatin analogs for use in the treatment of cancer |
| 05/30/2013 | US20130136832 Methods of preservation |
| 05/30/2013 | CA2856591A1 2-iodoimidazole derivatives |
| 05/29/2013 | EP2597086A1 Cyclic n,n'-diarylthioureas and n,n'-diarylureas as androgen receptor antagonists, anti-cancer agent, method for producing and using same |
| 05/29/2013 | CN101289485B Absorption of nucleic acids to solid phases under low-salt conditions |
| 05/28/2013 | US8450498 Ionic liquid epoxy resin monomers |
| 05/28/2013 | US8450356 Pharmaceutical composition |
| 05/28/2013 | US8450355 Compounds for the treatment of inflammatory diseases |
| 05/28/2013 | CA2561066C Antiviral 4-aminocarbonylamino-substituted imidazole compounds |
| 05/28/2013 | CA2539823C Hemiasterlin derivatives and uses thereof |
| 05/23/2013 | WO2013072591A1 Method for preparing pentacyclic anion salt |
| 05/23/2013 | WO2013072520A1 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 05/23/2013 | WO2013072470A1 Anions and derived salts with high dissociation in non-protogenic solvents |
| 05/23/2013 | WO2013014314A3 Derivatives of 5-azolone as calpain inhibitors |
| 05/23/2013 | CA2853254A1 N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapy |
| 05/23/2013 | CA2851041A1 Method for preparing pentacyclic anion salt |
| 05/22/2013 | EP2593438A1 Molecules having combinable groups |
| 05/22/2013 | EP2593437A1 Molecules having combinable groups |
| 05/22/2013 | CN103113303A Nitrogen heterocyclic compound used as CRTH2 (Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells) receptor antagonist |
| 05/22/2013 | CN102036959B Polysubstituted 2-aryl-6-phenyl-imidazo[l,2-a] pyridine derivatives, and preparation and therapeutic use thereof |
| 05/22/2013 | CN101316823B 2,4,5-triphenyl imidazoline derivatives as inhibitors of interaction between p53 and MDM2 proteins for use as anticancer agents |
| 05/21/2013 | US8445526 Compositions and methods for treatment of glaucoma |
| 05/21/2013 | US8445523 Dioxo-imidazolidine derivatives, which inhibit the enzyme SOAT-1, and pharmaceutical and cosmetic compositions containing them |
| 05/16/2013 | WO2013071203A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | WO2013069025A1 "process for the preparation of dexmedetomidine" |
| 05/16/2013 | WO2013067578A1 Modulators of c3a receptors |
| 05/16/2013 | US20130123493 Process for the synthesis of substituted urea compounds |
| 05/16/2013 | US20130123338 Novel cationic lipids and methods of use thereof |
| 05/16/2013 | US20130123315 Substituted imidazolones, compositions containing such compounds and methods of use |
| 05/16/2013 | US20130123215 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/16/2013 | CA2855390A1 2,5-dioxoimidazolidin-1-yl-3-phenylurea derivatives as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/15/2013 | CN103102313A Substituted aromatic vinyl imidazole compound and application thereof |
| 05/15/2013 | CN103102312A Cinnamyl imidazoline derivative, preparation and application thereof |
| 05/15/2013 | CN103102311A Cinnamyl imidazoline derivative and its preparation method and use |
| 05/15/2013 | CN103102310A Cinnamyl imidazoline derivatives and preparation method thereof |
| 05/14/2013 | US8440169 Stable isotope-labeled aromatic amino acids, method for incorporating the same in target protein and method for NMR-structural analysis of proteins |
| 05/14/2013 | CA2600649C Method and use of acidified modified polymers to bind biocides in paints |
| 05/14/2013 | CA2515856C Salts comprising cyanoborate anions |
| 05/10/2013 | WO2013064538A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/10/2013 | WO2013064153A1 Prodrugs of non- steroid anti - inflammatory agents (nsaids) |
| 05/10/2013 | CA2853006A1 Substituted benzylamine compounds, their use in medicine, and in particular the treatment of hepatitis c virus (hcv) infection |
| 05/09/2013 | US20130116437 Process and intermediates for preparing integrase inhibitors |
| 05/09/2013 | US20130116285 Chemical Compounds |
| 05/09/2013 | US20130116269 Cyclic n,n'-diarylthioureas and n,n'-diarylureas - androgen receptor antagonists, anticancer agent, method for preparation and use thereof |
| 05/08/2013 | EP2589595A1 Agent for treating hcv infection |
| 05/08/2013 | EP2588463A1 Metronidazole esters for treating rosacea |
| 05/08/2013 | EP2588462A1 Metronidazole esters for treating rosacea |
| 05/08/2013 | EP2588461A1 Metronidazole esters for treating rosacea |
| 05/08/2013 | EP2588460A1 Cosmetic use of n-substituted solfonyloxybenzylamines and related compounds |
| 05/08/2013 | EP2588450A1 Napht- 2 -ylacetic acid derivatives to treat aids |
| 05/08/2013 | CN103087295A Latent hyperbranched polymer curing agent and its preparation method |
| 05/08/2013 | CN103086979A Method for preparing imidazole aldehyde |
| 05/08/2013 | CN103086978A 1-methylimidazole preparation method |
| 05/08/2013 | CN103086977A Method for preparing 2-ethyl-4-methylimidazole |
| 05/08/2013 | CN103086976A Ion liquid and ion liquid-containing electric current type ammonia gas sensor |
| 05/08/2013 | CN103086975A 9-hydroxymethyl-10-imidazolanthracenehydrazone, and synthetic method and application thereof |
| 05/08/2013 | CN103086971A Nitrogenous heterocyclic derivative, preparation method thereof and application thereof in preparation of histone deacetylase I inhibitor |
| 05/08/2013 | CN103086925A Benzoyl urea derivatives having anticancer activity and their preparation method and use |
| 05/07/2013 | US8436104 Polymer |
| 05/07/2013 | US8436035 Organic compounds |
| 05/07/2013 | US8436023 Cyclohexyl-azetidinyl antagonists of CCR2 |
| 05/07/2013 | CA2735267C Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 05/02/2013 | WO2013063468A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | WO2013062027A1 Azole derivative |
| 05/02/2013 | WO2013061850A1 Organic electroluminescence element, display device, and lighting device |
| 05/02/2013 | WO2013036869A3 Compositions, methods, and systems for the synthesis and use of imaging agents |
| 05/02/2013 | US20130109866 Amide derivatives of n-urea substituted amino acids as formyl peptide receptor like-1 (fprl-1) receptor modulators |
| 05/02/2013 | US20130109865 Methods of preparing 1-(4-((1r,2s,3r)-1,2,3,4-tetrahydroxybutyl)-1h-imidazol-2-yl)ethanone |
| 05/02/2013 | US20130109863 Hetero-substituted acetanilide derivatives as analgesic agents |
| 05/02/2013 | US20130109684 Grp94 inhibitors |
| 05/02/2013 | US20130109019 Hapten conjugates for target detection |
| 05/02/2013 | US20130105766 Method For Removing Halogens From An Aromatic Compound |
| 05/02/2013 | CA2853522A1 Amino acid derivates functionalized on the n- terminal capable of forming drug incapsulating microspheres |
| 05/02/2013 | CA2853227A1 Azole derivative |
| 05/01/2013 | CN103079562A BACE inhibitors for use in the treatment of diabetes |
| 05/01/2013 | CN103073501A Ornidazole crystal compound |
| 05/01/2013 | CN103073500A Rare earth metal ionic liquid, preparation method and application thereof |
| 05/01/2013 | CN103073499A Method for preparing rhenium ion liquid by extraction method |
| 05/01/2013 | CN103073454A Synthetic method for beta-aminocarbonyl compound, beta-mercapto ketone and beta-alkoxy ketone |
| 05/01/2013 | CN102397275B Aromatization enzyme inhibitor |
| 05/01/2013 | CN101921261B Separation and recovery process after imidacloprid synthesis |
| 04/30/2013 | US8431717 Process for the preparation of 5-(2-ethyl-dihydro-1H-inden-2-yl)-1H-imidazole and salts thereof |
| 04/30/2013 | US8431716 Preparation of alkylimidazolidone (meth)acrylates in water |
| 04/30/2013 | US8431699 Method for manufacture of 2-oxoimidazolidines |
| 04/30/2013 | US8431607 Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 04/25/2013 | WO2012174164A3 Agonists of gpr131 and uses thereof |
| 04/25/2013 | US20130102789 Hafnium complexes of heterocyclic organic ligands |
| 04/25/2013 | US20130102592 Oxazole tyrosine kinase inhibitors |
| 04/25/2013 | CA2852917A1 Amine cationic lipids and uses thereof |
| 04/24/2013 | EP2582660A1 New cathepsin s protease inhibitors, useful in the treatment of e.g. autoimmune disorders, allergy and chronic pain conditions |
| 04/24/2013 | CN103061125A Halamine antibacterial agent containing reactive functional group, as well as preparation method and application for same |
| 04/24/2013 | CN103059062A Functionalized ion liquid and application thereof |
| 04/24/2013 | CN102391470B Preparation method for ionic liquid terminated polyurethane acrylate |
| 04/24/2013 | CN102079729B Compounds with antiparasitic activity and medicaments containing them |
| 04/24/2013 | CN101918368B Method for improving the hydrolysis stability of ionic liquids |
| 04/23/2013 | US8426587 Haloallylamine inhibitors of SSAO/VAP-1 and uses therefor |
| 04/23/2013 | US8426454 Therapeutic compounds |
| 04/18/2013 | WO2013054338A1 2-thio-imidazole derivatives as tgr5 modulators |
| 04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |